Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study
Abstract Despite recent accumulation on cardiovascular (CV) safety data on xanthine oxidase inhibitors (XOIs) among gout patients, assessment has been largely limited to macro- than micro-vascular disorders, prompting the investigation on the latter outcome. Therefore, we aimed to compare the risk o...
Saved in:
| Main Authors: | Min Jung Kim, Jung Yoon Pyo, Se Rim Choi, Anna Shin, Hokyung Choung, You-Jung Ha, Yun Jong Lee, Eun bong Lee, Eun Ha Kang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00551-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout
by: Ting-Syuan Lin, et al.
Published: (2025-07-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
A comparison of efficacy of Febuxostat and allopurinol in treatment of hyperuricemia in patients with chronic renal failure
by: CAI Hui, et al.
Published: (2016-01-01) -
Cardiovascular safety of febuxostat. Analysis of the CARES study
by: M. S. Eliseev
Published: (2018-12-01) -
Comparative efficacy and safety of febuxostat and allopurinol in chronic kidney disease stage 3–5 patients with asymptomatic hyperuricemia: a network meta-analysis
by: Jiaojiao Chen, et al.
Published: (2025-12-01)